NIHR funding for all UK-based Cochrane Review Groups ended on 31 March 2023 and so we have sought new partners for our evidence synthesis work. We are very pleased that we have been successful in obtaining funding to continue with a programme of CF reviews and evidence syntheses to support guidelines and share this information with our CF community. This grant has been funded by the CF Foundation and the UK CF Trust through to 31 March 2025 and we are looking forward to working with them closely over this time.
Our joy at this success is tempered by the fact that we will no longer be able to support our reviews and authors in the other areas of our scope, namely haemoglobinopathies, coagulopathies and inborn errors of metabolism. We would like to thank all our editors, authors, peer reviewers and consumers in these areas of our scope for their contribution to the Group’s success to date. We would not have been able to achieve this without your enthusiasm and dedication.